38
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Effect of Fumonisin Mycotoxins in Animals

&
Pages 293-302 | Published online: 28 Sep 2008
 

Abstract

Fumonisins are mycotoxins produced worldwide by Fusarium fungi, principally F. moniliforme. While this fungus can be cultured from virtually all harvested corn, fumonisin production is highly variable. Fumonisin ingestion induces a number of fatal diseases in animals, with the organ specificity being species dependent. The first animal toxicoses to be characterized were leukoencephalomalacia (‘‘moldy corn poisoning’’) in equines and pulmonary edema in swine. Fumonisins additionally produce mild to fatal toxicity in liver, kidney and heart in horses, pigs, cattle, sheep, chickens, ducks, rabbits, rats and mice. Prolonged administration of high doses of fumonisin B1 causes carcinoma of hepatocytes and bile ducts in rats. In man, habitual ingestion of corn products that contain a high concentration of fumonisins is associated epidemiologically with cancer of the esophagus.

The pathogenesis of injury to target organs is not understood completely. Affected kidneys and livers are characterized by individual cell death through apoptosis, with the degree of injury being related to dose and time of exposure. Fumonisins decrease sphingolipid synthesis through inhibition on sphinganine N-acetyltransferase (ceramide synthetase). This inhibition results in the accumulation of intracellular sphinganine and sphingosine. Excretion of sphinganine and sphingosine into the serum and urine of animals serves as a biomarker of fumonisin exposure. Inhibition of the ceramide synthase also results in decreased synthesis of complex sphingolipids and ceramide, a potent regulator of cell growth, cell differentiation, mitogenesis and apoptosis. The most sensitive target organs presumably are less tolerant of sphingolipid dysregulation.

Because fumonisins occur worldwide in livestock feed and human foods and are potent hepatotoxic and nephrotoxic compounds, investigators and clinicians are prudent to remain alert to possible fumonisin-related toxicity to these organs in both livestock and humans.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.